𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Scribed by Flavio Kruter; Mario Eisenberger; Victoria Sinibaldi; Christine Engstrom; Maria Jacobs; Jeffrey Abrams; Chandra Belani; William Gray; Steven Krasnow

Publisher
Springer US
Year
1992
Tongue
English
Weight
221 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of cisplatin and vinore
A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
✍ Enrique Espinosa; Pilar Zamora; Alfredo MillΓ‘; Serafin Morales; Raquel Molina; M πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv

A phase II study of cisplatin and contin
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer
✍ Eduardo Tellez-Bernal; Gonzalo Recondo; Thierry Guillot; Mohamed Benhamed; Chris πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 456 KB πŸ‘ 2 views

The chemotherapeutic treatment of recurrent and/or metastatic squamous cell carcinoma (SCC) of the head and neck (H & N) has a very dismal prognosis, with survival usually not exceeding 1 year. Reported objective response rates vary between 3% and 70%. This difference appears largely attributable to